Sarepta Therapeutics (SRPT) Other financing activities (2013 - 2026)

Sarepta Therapeutics' Other financing activities history runs 12 years deep, the most recent figure standing at $241000.0 for Q1 2026.

• In Q1 2026, Other financing activities fell 98.46% year-over-year to $241000.0; the TTM figure through Mar 2026 stood at $3.3 million (down 95.53% YoY), while the FY2025 annual figure was $18.7 million, down 76.48% from the prior year.
• Other financing activities for Q1 2026 stood at $241000.0, down from $308000.0 in the prior quarter.
• The five-year high for Other financing activities was $39.9 million in Q2 2024, with the low at $241000.0 in Q1 2026.
• The 5-year median for Other financing activities is $5.9 million (2023), against an average of $10.6 million.
• The sharpest annual moves came in 2023 and 2026: Other financing activities jumped 1628.91% in 2023, then plunged 98.46% in 2026.
• Sarepta Therapeutics' Other financing activities stood at $11.3 million in 2022, then sank by 82.81% to $1.9 million in 2023, then soared by 90.94% to $3.7 million in 2024, then tumbled by 91.7% to $308000.0 in 2025, then declined by 21.75% to $241000.0 in 2026.
• Business Quant data shows SRPT's Other financing activities at $241000.0 in Q1 2026, $308000.0 in Q4 2025, and $1.2 million in Q3 2025.